Key Points Research into the effect of semaglutide on breastfeeding is still emerging, but initial studies suggest minimal risk to breastfed babies Oral semaglutide (Rybelsus), however, is specifically not recommended during breastfeeding While early evidence is reassuring, long-term effects on infants remain unknown Healthcare providers still recommend caution and individualized decision-making You've heard about semaglutide's impressive weight loss results
Many compounded medications, including semaglutide, need to be kept in the refrigerator
Conditions that shorten red cell lifespan such as haemolytic anaemia or acute blood loss mean cells spend less time in circulation and accumulate less glycated haemoglobin, producing a spuriously low HbA1c even when blood glucose is elevated
You should not take weight loss treatments such as semaglutide (Wegovy or Ozempic) or tirzepatide (Mounjaro or Zepbound) while pregnant
How long does it take to see results from peptides
Who May Benefit from Peptide Research in the Future